Cargando…
Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2
Hereditary hemorrhagic telangiectasia (HTT) is an autosomal dominant disease, most frequently caused by a mutation in either ENG or ACVRL1, which can be associated with pulmonary arterial hypertension (PAH). In this report, we describe a new unpublished ACVRL1 mutation segregating in three members o...
Autores principales: | Greco, Alessandra, Plumitallo, Sara, Scelsi, Laura, Maggi, Giannantonio, Sobrero, Matteo, Turco, Annalisa, Raineri, Claudia, Arseni, Natalia, Cappelletti, Donata, Visconti, Luigi Oltrona, Pagella, Fabio, Spinozzi, Giuseppe, Ghio, Stefano, Olivieri, Carla, Danesino, Cesare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024275/ https://www.ncbi.nlm.nih.gov/pubmed/29799317 http://dx.doi.org/10.1177/2045894018782664 |
Ejemplares similares
-
BMPR2 mutations and response to inhaled or parenteral prostanoids: a case series
por: Scelsi, Laura, et al.
Publicado: (2021) -
Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy
por: Ghio, Stefano, et al.
Publicado: (2016) -
MitraClip procedure as ‘bridge to list’, the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension
por: Crimi, Gabriele, et al.
Publicado: (2018) -
Relationship between electrocardiographic findings and Cardiac Magnetic Resonance phenotypes in patients with Hypertrophic Cardiomyopathy
por: Fronza, Matteo, et al.
Publicado: (2016) -
Galectin-3 Plasma Levels Are Associated with Risk Profiles in Pulmonary Arterial Hypertension
por: Scelsi, Laura, et al.
Publicado: (2020)